|
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Pulmonary-Allergy Drugs Advisory Committee
May 1, 2007
Polly Parsons, M.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
David Schoenfeld, Ph.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
William Vollmer, Ph.D.
- 18 U.S.C. 208 waiver [pdf]
- Acknowledgement and Consent [pdf]
- Revised Acknowledgement and Consent (pdf) (Added April 30, 2007)
Page updated:
April 30, 2007
|
|